GSK "START", Tatarstan, Republic

Economic indicators

Net profit (RAS) of GSK START made up 0 RUB over 2023 compared to 179.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 4.05 million RUB in 2022.

Net profit (RAS) of GSK START dropped in 2022 by 6.28% to 179.00 thousand RUB from 191.00 thousand RUB over the same period in 2021, the company informed.

Revenue increased in the accounting period by 2.14% to 4.05 million RUB from 3.96 million RUB over 2021; cost of goods sold grew by 0.89% to 3.74 million RUB from 3.71 million RUB; sales profit went up by 20.63% to 304.00 thousand RUB from 252.00 thousand RUB.

Net profit (RAS) of GSK START made up 191.00 thousand RUB over 2021 compared to net loss of 54.00 thousand RUB over 2020, the company informed.

Revenue increased in the accounting period by 7.60% to 3.96 million RUB from 3.68 million RUB over 2020; cost of goods sold grew by 5.49% to 3.71 million RUB from 3.52 million RUB; sales profit went up 1.53 times to 252.00 thousand RUB from 165.00 thousand RUB.

Net loss (RA) of GSK START made up 54.00 thousand RUB over 2020 compared to net profit of 13.00 thousand RUB over 2019, the company informed.

Revenue increased in the accounting period by 0.63% to 3.68 million RUB from 3.66 million RUB over 2019; cost of goods sold grew by 2.45% to 3.52 million RUB from 3.43 million RUB; sales profit fell by 26.99% to 165.00 thousand RUB from 226.00 thousand RUB.

Companies in the region

• OBSCHESTVO DRUZHBY TATARSTAN-ARABSKIY VOSTOK
• Sadovodcheskoe nekommercheskoe tovarischestvo "VOSTOK"
• FIRMA "AMETIST"
• PYNAR
• TRIAS